Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03173157 · ClinicalTrials.gov registry record · NA
Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients
A NA study of Heart Failure and Heart Diseases, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 1
- Study location
NCT03173157: Completed NA study of Heart Failure and Heart Diseases, sponsored by Vanderbilt University Medical Center.
NCT03173157 is a NA study of Heart Failure and Heart Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 183 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03173157, a NA study of Heart Failure and Heart Diseases, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that a combined didactic and data feedback program presenting evidence based indications and in-hospital-charges for echocardiograms to inpatient cardiology team members will lead to increased health care value for patients on inpatient cardiology teams.
Primary Outcome
Average echocardiography charges per inpatient team per month
Conditions Studied
Interventions
- OTHER Value Feedback Email
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT03173157 record still lists
NCT03173157 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Value Feedback Email is the first listed.
NCT03173157 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03173157 about?
NCT03173157 is a clinical study titled "Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients". The investigators hypothesize that a combined didactic and data feedback program presenting evidence based indications and in-hospital-charges for echocardiograms to inpatient cardiology team members will lead to increased health care value for patients on inpatient cardiology teams.
What is the current status of trial NCT03173157?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2017-02-27. Estimated completion is 2017-12-31.
What conditions does trial NCT03173157 study?
This clinical trial studies the following conditions: Heart Failure, Heart Diseases.
What interventions are being tested in trial NCT03173157?
The interventions under investigation include: Value Feedback Email (OTHER).
Who is sponsoring clinical trial NCT03173157?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03173157 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03173157's enrollment target sits among peer trials
183 175th of 397 higher than 223 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI